via Pharmaceutical Journal
Saliva could be used instead of blood to monitor diabetes in a method proposed in research involving the University of Strathclyde.
The test has been developed as an alternative to the current prevalent practice of monitoring blood glucose, which can be invasive, painful and costly.
Lab tests of the saliva process had an accuracy rate of 95.2%. The research shows promising results for monitoring diabetes, which affects an estimated 425 million people worldwide – around half of them undiagnosed.
The research has been published in the journal PLOS One. It also involved partners at the Federal University of Uberlandia in Minas Gerais, Brazil, the University of Vale do Paraíba in Sao Paolo, Brazil and the University of Saskatchewan in Canada.
Dr Matthew Baker, a Reader in Strathclyde’s Department of Pure and Applied Chemistry and lead researcher in the project, said: “Frequent monitoring of diabetes is essential for improved glucose control and to delay clinical complications related to the condition. Early screening is also paramount in reducing these complications worldwide.
“Blood analysis for screening, monitoring and diagnosing diabetes is widely practised but is quite invasive and painful. The constant need of piercing the fingers several times daily for most patients may lead to the development of finger calluses, as well as difficulty in obtaining blood samples; furthermore, not everyone would want to give blood and there are circumstances in which it could be dangerous.
“Saliva reflects several physiological functions of the body, such as emotional, hormonal, nutritional and metabolic, and so its biomarkers could be an alternative to blood for robust early detection and monitoring. It is easy to collect, non-invasive, convenient to store and requires less handling than blood during clinical procedures, while also being environmentally efficient. It also contains analytes with real-time monitoring value which can be used to check a person’s condition.”
Dr Robinson Sabino-Silva, an associate professor at Federal University of Uberlandia (UFU) and a partner in the research, said: “The present protocol used in the infrared platform is able to detect spectral biomarkers without reagents. The combination of a non-invasive salivary collection and a reagent-free analysis permit us to monitor diabetes with a sustainable platform classified as green technology.“
The lab tests used a scientific system known as Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. This has been used in the diagnosis of several diseases, although its applications in the monitoring of diabetic treatment have begun to emerge only recently. Samples were assessed in three categories – diabetic, non-diabetic and insulin-treated diabetic – and two potential diagnostic biomarkers were identified.
The researchers are hopeful that the process they have developed could be used for both Type 1 and Type 2 diabetes, although further study will be required to confirm this.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Monitoring diabetes
- Galaxy Watch 7 rumor puts blood sugar monitoring back on the table
A report suggests Samsung may implement blood sugar monitoring capabilities on the Galaxy Watch 7 later in 2024. Samsung's Hon Pak stated the company is looking to bring blood sugar and diabetes ...
- Remove barriers to getting diabetes technologies
Twenty-five years into the use and development of diabetes maintenance with CGMs, proven to decrease overall costs and increase standard of living, it is time for these barriers to be removed.
- Samsung Galaxy Watch 7 Rumoured To Have Blood Sugar Monitoring
Leaks and rumours have been picking up pace about the Samsung Galaxy Watch 7 series. The lineup is expected to comprise of three models compared to two models indicating a shift in strategy. Now, a ...
- Pharmac ponders glucose monitor funding
Government drug buying agency Pharmac is looking at covering the cost of continuous glucose monitors for type 1 beabetics. Type1 diabetes, which affects about 28-thousand New Zealanders, is managed ...
- NFL tight end Mark Andrews wants to inspire others with diabetes both on and off the field
Mark Andrews, a tight end for the Baltimore Ravens, has never let his type 1 diabetes slow him down on the field or off it. He aims to inspire others with his story and his accomplishments despite his ...
Go deeper with Google Headlines on:
Monitoring diabetes
[google_news title=”” keyword=”monitoring diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Diabetes
- Semaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like Ozempic
Medications like Ozempic and Mounjaro have revolutionized the treatment of Type 2 diabetes and obesity — and they have grown in popularity as well.
- Catherine C. Genthner, dietician who started her own diabetes practice, dies
Catherine C. Genthner, an institutional dietician who later maintained a private practice, died April 15 at her Timonium home. She was 71.
- The Local Doctor is in for Everyday Solutions: Diabetes and Prevention
Dr. Zunin is The Local Doctor is In for Everyday Solutions and today he talked about the Diabetes Association's is Step Out Walk at Kapiolani Park. Dr. Zunin talked about Diabetes and what actually ...
- Preparing to pedal in fight to end diabetes
This weekend, hundreds of riders are gearing up for Tour de Cure. It's a ride to help raise money in the fight to end diabetes.
- Remove barriers to getting diabetes technologies
Twenty-five years into the use and development of diabetes maintenance with CGMs, proven to decrease overall costs and increase standard of living, it is time for these barriers to be removed.
Go deeper with Google Headlines on:
Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]